Why is St. Jude an excellent place for my child's stem cell / bone marrow transplant?

St. Jude has one of the world’s largest hematopoietic stem cell / bone marrow transplant programs dedicated to caring for children, adolescents and young adults. Since the first hematopoietic bone marrow transplant at St. Jude was performed in 1982, the Transplant Program has treated more than 1,000 children. To improve outcomes and reduce side effects associated with transplantation, physicians in the St. Jude Transplant Program work closely with laboratory scientists to rapidly apply new developments or findings made in the laboratory to the care of patients. The program accomplishes these goals by conducting clinical trials to study these new innovations. To provide comprehensive care, a close-knit group of physicians in the Transplant Program work closely with support staff in rehabilitation medicine, nursing, pathology, radiation oncology, pharmacy, psychology, clinical nutrition, child life and social work. These support personnel have been specifically trained in caring for pediatric patients who receive hematopoietic stem cell / bone marrow transplants.

Since 1962, St. Jude Children’s Research Hospital has treated more than 17,000 children with various catastrophic diseases. St. Jude is the only pediatric cancer center funded by the U.S. National Cancer Institute and the only private U.S. cancer center committed to caring for and supporting children with cancer or other catastrophic diseases, regardless of the financial or health care resources of the families.

 

Last update: October 2003